ABSTRACT: This study aimed to evaluate the chondroprotective and anti-inflammatory activity of brazilin in human osteoarthritic (OA) cartilage and chondrocytes with particular focus on the nuclear factor-kappa B (NF-kB) pathway. Therefore, brazilin was isolated from Caesalpinia sappan and identified using high performance liquid chromatography (HPLC). The effect of brazilin was assessed in cartilage explants treated with 10 ng/ml interleukin (IL)-1b and 10 ng/ml tumor necrosis factor (TNF)-a using histological and biochemical glycosaminoglycan (GAG) analyses and in primary chondrocytes treated with 10 ng/ml IL-1b using RT-qPCR, ELISA, and Western blot. The involvement of NF-kB signaling was examined using a human NF-kB signaling array and in silico pathway analysis. Brazilin was found to reduce the GAG loss from cartilage explants stimulated with IL-1b and TNF-a. NF-kB pathway analysis in chondrocytes revealed NFKB1/p50 as a central player regulating the anti-inflammatory activities of brazilin. Brazilin suppressed the IL-1b-mediated up-regulation of OA markers and the induction of NFKB1/p50 in chondrocytes. In conclusion, brazilin effectively attenuates catabolic processes in human OA cartilage and chondrocytes-at least in part due to the inhibition of NFKB1/p50-which indicates a chondroprotective potential of brazilin in OA. ß
In addition to biomechanical factors and ageing, inflammatory conditions have been recognized as important contributors to OA progression. 1 The NF-kB pathway thereby acts as central regulator that activates normally quiescent chondrocytes and induces their catabolic activity by increasing the expression of inflammatory mediators and matrix-degrading enzymes. 2 As a substantial initiator of inflammatory processes, NF-kB seems to be a promising therapeutic target.
The heartwood of Caesalpinia sappan L. has been widely used in traditional Chinese medicine. 3 We previously set out to evaluate the biological activity of an ethanolic extract from C. sappan (CSE) 4, 5 showing that CSE significantly suppressed the IL-1b-mediated up-regulation of matrix metalloproteinase (MMP)-13 mRNA and protein levels via abrogation of the NF-kB(p65/p50)-driven MMP-13 promoter activation. 4 Similarly, the inhibition of cyclooxygenase-2 transcription was related to the suppression of the p65/p50-driven transactivation of its promoter. 5 In general, brazilin, the major component of CSE, has been shown to possess anti-oxidative, anti-inflammatory, anti-bacterial, and anti-hepatotoxic activities. 6, 7 Of note, we recently found that CSE and five isolated compounds, especially brazilin, showed significant anti-inflammatory properties in macrophage and chondrocyte cell lines. 8 In consequence, the present study was designed to assess these beneficial properties of brazilin in the context of cartilage degeneration, evaluating its antiinflammatory and chondroprotective potential in cytokine-stimulated OA cartilage explants and chondrocytes, with particular focus on the NF-kB pathway.
MATERIALS AND METHODS

Isolation and Identification of Brazilin
As previously described, 8 brazilin was isolated from CSE by repeated preparative HPLC separations. The purity and identity of brazilin was confirmed using analytical HPLC in comparison to a standard preparation that has been previously identified using 1 H-NMR and 13 C-NMR spectroscopy, 5, 8 demonstrating the successful purification of chemically pure brazilin (!95%; (6aS,11bR)-7,11b-dihydroindeno[2,1-c]chromene-3,6a,9,10(6H)-tetrol; C 16 H 14 O 5 ) suitable for molecular biological activity assays.
Clinical Specimens
In accordance with the terms of the ethics committee of the Medical University of Vienna (EK-Nr.: 1065/2011) and following the guidelines of the Declaration of Helsinki and Tokyo, articular cartilage for histological analysis and chondrocyte isolation was obtained with written informed consent from patients with clinical and radiographic signs of OA (13 female, 4 male; age range 55-82 years; Knee Society Scores: Knee Score 26-68, Functional Score 25-60) undergoing knee replacement surgery.
Explant Culture
Full depth osteochondral explants were obtained from femoral condyles (n ¼ 3 donors; two female, one male; age range 61-82 years; Knee Society Scores: Knee Score 37-65, Functional Score 30-50) using a 5-mm biopsy punch. The explants were intensively washed with phosphate buffered saline (PBS) and cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Life Technologies, Carlsbad, CA) supplemented with insulin-transferrin-selenium solution (ITS; Gibco) and 100 mg/ml gentamicin (Gibco). Treatment was performed with: (1) a combination of 10 ng/ml IL-1b and 10 ng/ml TNF-a; (2) 10 mg/ml brazilin plus 10 ng/ml IL-1b and 10 ng/ml TNF-a; or (3) medium alone for the untreated controls. After 7 days of culture, the medium and the explants were collected and processed for GAG analysis and histology.
Histological GAG Staining
The explants were fixed in 7.5% formalin (SAV Liquid Production, Flintsbach am Inn, Germany) for 5 days and decalcified using Titriplex-Tris-Solution (Gatt-Koller, Absam, Austria) for another 5 days. Then, the explants were dehydrated and embedded in paraffin according to standard procedures. Five to ten randomly selected paraffin sections (2.5 mm) obtained throughout the diameter of the explants were stained with Safranin O (Sigma-Aldrich, St. Louis, MO) and counter-stained using light-green Goldner III solution (Morphisto, Frankfurt, Germany).
GAG Loss Analysis
The release of GAG from explants (n ¼ 3 donors) into the culture medium was measured using the Blyscan Sulfated Glycosaminoglycan Assay (Biocolor, Carrickfergus, UK), following the manufacturer's instructions. Optical absorbance at 656 nm was measured with a microplate reader (Fluostar-Optima, BMG-Labtech, Ortenberg, Germany). GAG content was then determined from a standard curve prepared from chondroitin-4 sulfate (provided with the kit).
Cell Culture
Primary human OA chondrocytes were enzymatically isolated from femoral condyles and tibial plateaus of OA patients (n ¼ 14 donors; 11 female, 3 male; age range 55-77 years; Knee Society Scores: Knee Score 26-68, Functional Score 25-60) following established protocols. 9 Chondrocytes were seeded at a density of 10 5 /cm 2 in DMEM containing 10% fetal calf serum (Biochrom, Cambridge, UK) and 100 mg/ ml gentamicin in a humidified atmosphere of 5% CO 2 /95% air at 37˚C. For all assays, only freshly isolated and seeded chondrocytes without subculturing were used. Prior to treatment, primary chondrocytes were starved overnight in serum-free DMEM supplemented with gentamicin. Then, cells were pre-treated for 1 h with 10 mg/ml brazilin in serum-free medium followed by the addition of 10 ng/ml IL-1b, or 10 ng/ml or 40 ng/ml TNF-a, and further co-incubation for the indicated time periods. For a comparison of the effects of brazilin with those of a well-known NF-kB inhibitor, caffeic acid phenethyl ester (CAPE; Calbiochem, EMD Millipore, Billerica, MA), chondrocytes were pre-treated for 1 h with 2.5, 5, or 10 mg/ml brazilin or 5, 10, or 20 mg/ml CAPE prior to the addition of 10 ng/ml IL-1b for 6 h. The immortalized human chondrocytic cell line, C-28/I2, 9 and the human chondrosarcoma cell line, SW1353 (ATCC À HTB-94, Manassas, VA), were cultured at a density of 10 4 /cm 2 under the same conditions as described above and passaged by incubation with 0.25% trypsin-EDTA. Both cell lines were starved overnight in serum-free DMEM supplemented with gentamicin. C-28/I2 cells (n ¼ 6) were pre-treated for 1 h with 5 or 10 mg/ml brazilin followed by the addition of 10 ng/ml IL-1b and 10 ng/ml TNF-a for 6 h. SW1353 cells (n ¼ 6) were pre-treated with 5 or 10 mg/ml brazilin for 1 h prior to the addition of 10 ng/ml IL-1b for 6 h. For all experiments, untreated controls and cytokine-stimulated controls were included.
Cytotoxicity Assay
The cytotoxicity of 0.625-40 mg/ml brazilin was assessed for 72 h in primary human chondrocytes using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-based test (EZ4U, Biomedica, Vienna, Austria) following the manufacturer's instructions.
RT-qPCR
Total RNA was extracted using the NucleoSpin RNA II Kit (Macherey-Nagel, Dueren, Germany). Each sample was run on the Agilent 2100 Bioanalyzer Nano LabChip (Agilent Technologies, Santa Clara, CA) for quality control and quantification of total RNA prior to reverse transcription into cDNA using the high capacity cDNA reverse transcription kit (Applied Biosystems, Life Technologies). RNA integrity numbers were between 9.3 and 10. SYBR-green-based qPCR assays for the target transcripts were used as described. 4, 5, 10 A qPCR checklist listing all relevant information is provided to document the technical adequacy of the qPCR protocols (Fig. S1 ).
MMP ELISA
Primary human OA chondrocytes were seeded in 25-cm 2 flasks (TPP, Techno Plastic Products, Trasadingen, Switzerland) and cultured as described above. Cells were either treated for 24 h with 10 ng/ml IL-1b, or pre-treated for 1 h with 10 mg/ml brazilin followed by the addition of 10 ng/ml IL-1b for 24 h. Untreated chondrocytes served as controls. Afterwards, cell culture supernatants were collected, centrifuged at 4˚C and 1,000 rpm (Hettich Universal 30 RF, Andreas Hettich, Tuttlingen, Germany) for 10 min and stored at À80˚C. The quantitative determination of human pro-MMP-1 (n ¼ 6 donors), total MMP-3 (n ¼ 3 donors), and human pro-MMP-13 (n ¼ 6 donors) concentrations in cell culture supernatants was carried out using Quantikine ELISA kits (R&D Systems, Minneapolis, MN), following the protocols provided by the manufacturer.
NF-kB Array
The effects of brazilin on the expression of 84 genes associated with NF-kB signal transduction were examined using the human NF-kB signaling pathway RT 2 Profiler PCR array (SABiosciences, QIAGEN, Hilden, Germany), according to the manufacturer's instructions. In brief, chondrocytes of OA patients (n ¼ 2 donors) were starved and pre-treated for 1 h with 10 mg/ml brazilin, followed by the addition of 10 ng/ml IL-1b for 6 h. Untreated cells and cells stimulated with IL-1b served as controls. Data obtained from the array were analyzed using an Excel-based data analysis template provided by the manufacturer.
Gene networks representing key genes for the antiinflammatory activity of brazilin were identified using GNCPro (SABiosciences). This free in silico research tool allows for collating gene and pathway interactions with integrating collective biological knowledge through text mining, data mining, data acquisition, and computational prediction. The interactions among a group of genes are presented graphically and interactively. 
Western Blot Analysis
Western blot analysis was performed as previously described. 11 In brief, proteins were isolated from primary human OA chondrocytes or SW1353 cells, separated using SDS-PAGE, and transferred to a nitrocellulose membrane. After blocking, the membranes were probed for 2 h with primary antibodies: Anti-NF-kB p105/p50 (1:400, ab7971, rabbit polyclonal; Abcam, Cambridge, MA), anti-NF-kB p65 (1:1,000, rabbit monoclonal; Cell Signaling Technology, Danvers, MA), anti-phospho-NF-kB p65 (Ser536, 1:1,000, rabbit monoclonal; Cell Signaling Technology), anti-a-tubulin (1:1,000, mouse monoclonal; Cell Signaling Technology) and anti-b-actin (1:5,000, mouse monoclonal; Sigma-Aldrich). Then, the membranes were incubated for 1 h with the respective secondary antibodies: DyLight 800 nm labeled anti-rabbit IgG made in goat (Thermo Fisher Scientific, Waltham, MA) or IRDye 680LT anti-mouse IgG made in goat (LI-COR Biosciences, Bad Homburg, Germany). Finally, the immunoreactive protein bands were detected and quantified using the Odyssey Imager with Image Studio Software (LI-COR Biosciences). The protein levels of NFKB1/p50 were calculated as percentages relative to the untreated control set at 100%, considering normalization to b-actin as reference protein.
Statistics
Data obtained from primary chondrocytes and cartilage explants were exported to R version 3.4.1 for statistical analysis using non-parametric tests as indicated in the Figure legends. Quade test with pairwise comparison using Quade's post-hoc test was applied for experiments with n < 5 patients. Friedman test with pairwise comparison as reported by Eisinga et al. 12 was used for experiments with n > 5 patients, or if the use of a many-to-one post-hoc test was required. Correction for multiple comparisons was performed using Benjamini-Hochberg procedure. Data obtained from chondrocytic cell lines were exported to SPSS 24.0 for statistical analysis using one-way ANOVA with Tukey post-hoc test, following verification of normal distribution using Shapiro Wilk test. p-Values <0.05 were considered significant.
RESULTS
Brazilin Reduces Cytokine-Mediated GAG Release From Cartilage Explants of OA Patients Safranin O staining of the histological sections of the cartilage explants (n ¼ 3 donors) showed a massive loss of GAG in the cytokine-stimulated explants compared to untreated controls, whereas those explants co-treated with brazilin showed hardly any loss of GAG (Fig. 1a) . These results were corroborated by measuring the GAG release from the explants into the cell culture supernatants. As shown in Figure 1b , treatment with IL-1b/TNF-a increased the GAG release as compared to controls, whereas the presence of brazilin reduced the GAG release from cartilage explants. Albeit not statistically significant, this trend was reproducible in all three individual experiments, suggesting the chondroprotective activity of brazilin against IL-1b/TNF-a.
Brazilin Inhibits OA Marker Gene Expression and Protein Secretion in Human Chondrocytes
Brazilin concentrations of up to 40 mg/ml did not induce any cytotoxicity in cultured primary chondrocytes. In agreement with our previous study, 8 brazilin was used at a concentration of 10 mg/ml for ensuing experiments. Since treatment with 10 ng/ml and 40 ng/ml TNF-a induced no significant up-regulation of IL1B and MMP13 mRNA levels in OA chondrocytes of this study (data not shown), only 10 ng/ml IL-1b were used for the following experiments. The mRNA levels of IL1B (Fig. 2a) , TNF (Fig. 2b), PTGS2 (Fig. 2c), NOS2 (Fig. 2d) , and ADAMTS4 (Fig. 2e) were significantly increased in primary human chondrocytes (n ¼ 4 donors) following stimulation with 10 ng/ml IL-1b over 6 h (p < 0.05). However, pre-treatment with brazilin for 1 h blocked the expression of IL-1b-induced genes (p < 0.05 in case of TNF, PTGS2, and NOS2; p ¼ 0.07 in case of IL1B and ADAMTS4). Of note, IL-1b treatment reduced COL2A1 mRNA levels (Fig. 2f) , whereas brazilin tended to antagonize this effect (p ¼ 0.08). Moreover, IL-1b treatment significantly up-regulated mRNA levels of MMP1 (Fig. 2g), MMP3 (Fig. 2h) , and MMP13 (Fig. 2i) , whereas pre-treatment with brazilin reduced this induction (p < 0.05 in case of MMP3; p ¼ 0.07 in case of MMP1 and MMP13). Besides, the activity of brazilin on PTGS2 mRNA expression was also reproduced in cytokine-treated C-28/I2 (Fig. S2a) and SW1353 (Fig. S2b) cells, as well-established chondrocyte models. In agreement, treatment of OA chondrocytes with 10 ng/ml IL-1b for 24 h markedly increased pro-MMP-1 (Fig. 2j) , MMP-3 ( Fig. 2k) and pro-MMP-13 ( Fig. 2l ) secretion into cell culture supernatants, whereas pre-treatment with brazilin significantly reduced the production of all three matrix metalloproteinases (p< 0.05).
Brazilin Interferes With Mediators of the NF-kB Signaling Pathway
We examined the effects of brazilin on the expression of 84 genes associated with NF-kB-mediated signal transduction. When treated for 6 h with 10 ng/ml IL-1b, 24 of these 84 genes were significantly up-regulated (p < 0.05 and >2 fold change) in OA chondrocytes. From these 24 genes, we found nine genes (BIRC3, CCL2, CSF1, CSF3, CXCL8, IL1B, NFKB1, NFKB2, and TNFAIP3) to be significantly down-regulated by pre-incubation with brazilin (Fig. 3a , p < 0.05 and >2 fold change). The other 15 genes were up-regulated by IL-1b but not significantly down-regulated with brazilin (Fig. S3) . The use of the GNCPro in silico research tool allowed us to combine the nine significantly regulated genes in a network describing their mutual activities, including co-expression, up-or down-regulation, physical interaction, or transcription factor regulation. This pathway analysis suggested NFKB1 as one major player in the anti-inflammatory activities of brazilin (Fig. 3b) .
Brazilin Targets NFKB1 Then, we aimed to verify the relevance of NFKB1/p50 for the activity of brazilin in human chondrocytes. Cells were therefore either treated with 10 ng/ml IL-1b or pre-treated with brazilin prior to IL-1b-stimulation. Initially, we performed RT-qPCR assays and found a pronounced up-regulation of NFKB1 mRNA in IL-1b-stimulated primary chondrocytes (p < 0.05, n ¼ 4). Of note, this effect was significantly reduced by pre-treatment with brazilin (p < 0.05; Fig. 4a ). Proceeding from mRNA to protein levels, we initially monitored the presence of the NF-kB pathway components p50, p65, and phosphorylated p65 over time in IL-1b-stimulated primary chondrocytes by Western blot analyses ( Fig. 4b ; for p50 in SW1353 cells please see Fig. S2c ) to find the appropriate time point for studying the effects of brazilin on the respective proteins. Primary chondrocytes (n ¼ 4) treated with Figure 2 . Brazilin reduces the effects of IL-1b on gene expression and protein secretion in primary chondrocytes. Primary chondrocytes (n ¼ 4 donors) were left untreated (C), treated with 10 ng/ml IL-1b for 6 h, or pre-treated with 10 mg/ml brazilin for 1 h prior to stimulation with 10 ng/ml IL-1b for 6 h. The mRNA levels of (a) IL1B, (b) TNF, (c) PTGS2, (d) NOS2, (e) ADAMTS4, (f) COL2A1, (g) MMP1, (h) MMP3, and (i) MMP13 were analyzed using RT-qPCR and are given as relative quantities (mean AE SD) compared to controls. Concentrations (ng/ml) of (j) proMMP-1, (k) total MMP-3, and (l) proMMP-13 were measured in cell culture supernatants of primary chondrocytes (n ¼ 3-6 donors) which were left untreated (C), treated with 10 ng/ml IL-1b for 24 h, or pretreated with 10 mg/ml brazilin for 1 h prior to stimulation with 10 ng/ml IL-1b for 24 h. Ã Significant differences compared to untreated cells (p < 0.05; Quade test). 10 ng/ml IL-1b for 24 h showed increased presence of p50 (216 AE 59%; in comparison to untreated cells set to 100%), while 1 h pre-treatment with brazilin reduced these amounts below basal levels (68 AE 16%; Fig. 4c ). This finding could also be reproduced in SW1353 cells, where treatment with IL-1b also increased the p50 presence (467 AE 101%), while pre-treatment with brazilin decreased p50 levels (54 AE 15%; Fig. S2d ). In addition, 1 h stimulation of chondrocytes with 10 ng/ml IL-1b induced the phosphorylation of p65. However, this effect was blocked by 1 h pre-treatment with brazilin (Fig. 4d) . To confirm that the beneficial effects of brazilin are mediated by interfering with NF-kB signaling, we compared the effects of brazilin to those of a well-known NF-kB inhibitor (i.e., CAPE). Thereby, we could verify that both brazilin and CAPE dosedependently blocked the mRNA expression of IL1B (Fig. 4e) , TNF (Fig. 4f), PTGS2 (Fig. 4g) , and MMP13 (Fig. 4h) .
DISCUSSION
Established pharmacological therapies are not able to adequately target the dysregulated molecular processes responsible for OA onset, and they also fail to prevent progressive cartilage degradation. Joint replacement will sooner or later be the only treatment option when all other therapies fail. As inflammation represents one hallmark of OA, novel drugs that specifically interfere with inflammatory processes and their mediators are urgently needed to support and advance current therapeutic and prophylactic strategies. Already in the past, the potential of various phytochemical compounds for medical application has been recognized. Regarding OA therapy, numerous attempts have been made in the recent years to evaluate different plant extracts for clinical use. 13, 14 Due to its diverse pharmacological activities including anti-inflammatory properties, 7 brazilin might be a promising new substance for OA therapy.
In the present report, we show that 10 mg/ml brazilin effectively decreased the GAG loss of human cartilage explants treated with 10 ng/ml IL-1b and TNF-a. It is well documented that IL-1b and TNF-a reduce proteoglycan and collagen synthesis by chondrocytes, and increase inflammatory mediator production, as well as MMP gene expression and secretion, resulting in cartilage matrix loss. 15 The activity of brazilin was then further assessed in primary human chondrocytes, as well as in C-28/I2 and SW1353 cell models. When incubated with 10 ng/ml IL-1b, cultured chondrocytes responded with a well-known pattern of induced OA marker genes such as IL1B, TNF, PTGS2, and NOS2. COL2A1 gene expression, in contrast, was downregulated, as shown previously. 16, 17 Of note, the concentration of 10 ng/ml IL-1b and TNF-a which we used in our study for cartilage explant and chondrocyte treatment was markedly higher than the range of these cytokines reported in the synovial fluid of OA patients, which has been reported to be 1.21 AE 0.01 pg/ml to 6 AE 18 pg/ml for IL-1b and 3.09 AE 1.38 pg/ml to 4 AE 20 pg/ml for TNF-a. [18] [19] [20] However, based on our own experimental experience and in line with common approaches in the literature, the applied cytokine concentrations in the present study were deliberately chosen to induce a maximized inflammatory response in vitro. 4, 5, 8, [21] [22] [23] [24] [25] We found that pre-treatment with 10 mg/ml brazilin counteracted these pro-inflammatory and catabolic effects achieved by cytokine stimulation in cartilage explants and chondrocytes. Of importance, brazilin also effectively prevented the induction of MMP-1, MMP-3, and MMP-13 by IL-1b at both the gene and protein levels, as well as the induction of ADAMTS4 mRNA. Exacerbated production of MMPs and ADAMTS is a key event in the progression of OA and represents a promising target for the management of OA. 14, [26] [27] [28] In an attempt to elucidate the molecular mechanisms underlying the beneficial properties of brazilin, we pursued initial evidence on the involvement of the NF-kB pathway. [29] [30] [31] Thereby, we could show that brazilin inhibits a network of genes associated with NF-kB signaling as well as the amount of p50 and the phosphorylation of p65 in IL-1b-stimulated OA chondrocytes. These results extend previous data showing that brazilin reduces LPS-or TNF-induced NF-kB Figure 3 . Brazilin inhibits gene expression of mediators of the NF-kB signaling pathway. Primary chondrocytes (n ¼ 2 donors) were left untreated (Control), treated in triplicate with 10 ng/ml IL-1b for 6 h, or pre-treated with 10 mg/ml brazilin for 1 h prior to stimulation with 10 ng/ml IL-1b for 6 h. The impact of brazilin on the expression of 84 genes related to the NF-kB pathway was assessed using the RT 2 Profiler PCR array. (a) Nine genes that were induced by IL-1b were significantly down-regulated by brazilin (p < 0.05 and >2-fold change). (b) Gene networks representing key gene targets for brazilin activity were identified using GNCPro.
BRAZILIN BLOCKS CATABOLIC PROCESSES VIA INHIBITION OF NFKB1/p50
activation in fibroblast-like synoviocytes obtained from rheumatoid arthritis (RA) patients. 32 Clearly, in vitro assay conditions fail to allow direct extrapolation of results to human application, particularly in terms of pharmacokinetic parameters, such as bioavailability at the site of action, metabolism, and safety. Regarding the application of brazilin in vivo, toxicological studies have been conducted in animal models with extracts of C. sappan and brazilin. [33] [34] [35] [36] Thereby, pharmacokinetics and tissue distribution have been determined. Although orally and intravenously administered brazilin achieved similar plasma half-life, injection 34 improves bioavailability compared to oral administration. 36 Yan-yan et al. 34 detected a maximum plasma concentration of 82.2 AE 9.6 mg/ml after intravenous administration of 100 mg/kg brazilin in rats, while Deng et al. 36 measured a maximum plasma concentration of 3.4 AE 1.1 mg/ml after oral administration of 100 mg/kg in rats. The choice of 10 mg/ml brazilin which we applied in our in vitro study on chondrocytes is based on previous experiments 8 and also fits in the range of plasma levels achieved during brazilin treatment in animal models. Moreover, Jia et al. 35 studied tissue distribution and excretion of brazilin after intravenous administration in rats and found that brazilin was eliminated primarily by the kidneys. Due to the generally low levels of brazilin in urine and feces, Jia and colleagues concluded that brazilin might undergo extensive hepatic metabolism and therefore suggested the monitoring of liver function during treatment which might be an important information for future clinical studies. 35 Applied in animal models of RA, daily oral treatment with CSE markedly attenuated collagen-induced arthritis (CIA) and reduced the levels of IL-1b, IL-6, TNF-a and PGE2 in serum and the expression of COX-2 and NF-kB/p65 in paw cartilage. 37 Also, intraperitoneal administration of brazilin isolated from C. sappan was found to markedly attenuate CIA in mice and to reduce the serum levels of inflammatory cytokines. 38 In mice, brazilin was also reported to have therapeutic potential in preventing bone loss. 39 However, to the best of our knowledge, studies evaluating the effect of brazilin in weight-bearing joints or articular cartilage-in vivo or in vitro-have been missing. The present study therefore represents a first step towards the evaluation of brazilin in the context of human OA reporting that brazilin might protect cartilage matrix from cytokine-induced degradation. Brazilin was administered as a pre-treatment prior to cytokine stimulation of cartilage explants and chondrocytes. Although representing a scenario with clinically limited applicability, this approach was deliberately Figure 4 . Brazilin inhibits NFKB1/p50. (a) Primary human chondrocytes (n ¼ 4 donors) were left untreated (C), treated with 10 ng/ml IL-1b for 6 h, or pre-incubated with 10 mg/ml brazilin for 1 h prior to stimulation with 10 ng/ml IL-1b for 6 h. NFKB1 mRNA levels were analyzed by RT-qPCR and expressed as relative quantities (mean AE SD) compared to controls. Ã Significant differences compared to untreated cells (p < 0.05; n ¼ 4; Quade test). # Significant differences compared to cells treated only with IL-1b (p < 0.05; n ¼ 4; Quade test). (b) Primary human chondrocytes (n ¼ 4 donors) were left untreated (C) or were treated with 10 ng/ml IL-1b for 15 min, 1 h, 4 h, 16 h, and 32 h. Protein extracts were subjected to Western blot analysis for the detection of p50, p65, and phosphorylated p65. b-Actin and atubulin were used as loading controls. The blot of one representative experiment is shown. (c) Primary chondrocytes (n ¼ 4) were left untreated (C), treated with 10 ng/ml IL-1b for 24 h, or pre-treated with 10 mg/ml brazilin for 1 h prior to stimulation with 10 ng/ml IL-1b for 24 h. Protein extracts were subjected to Western blot analysis for the detection of p50. b-Actin was used as loading control. The blot of one representative experiment is shown. (d) Primary chondrocytes (n ¼ 4) were left untreated (C), treated with 10 ng/ml IL-1b for 1 h, or pre-treated with 10 mg/ml brazilin for 1 h prior to stimulation with 10 ng/ml IL-1b for 1 h. Protein extracts were subjected to Western blot analysis for the detection of p65 and phosphorylated p65. a-Tubulin was used as loading control. The blot of one representative experiment is shown. (e-h) Primary chondrocytes (n ¼ 3 donors) were left untreated as controls, treated with 10 ng/ml IL-1b for 6 h, or pre-treated with 2.5, 5, and 10 mg/ml brazilin or 5, 10, and 20 mg/ml CAPE for 1 h prior to stimulation with 10 ng/ml IL-1b for 6 h. The mRNA levels of (e) IL1B, (f) TNF, (g) PTGS2, and (h) MMP13 were analyzed by RT-qPCR and expressed as percent relative to cells treated with IL-1b (100%). Ã Significant differences compared to cells treated only with IL-1b (p < 0.05; n ¼ 3; Friedman test with manyto-one post-hoc test).
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WEINMANN ET AL. chosen to optimize the conditions for the elaboration of molecular effects in vitro. It will be interesting to assess the efficacy of brazilin in further pre-clinical models and clinical trials of OA, also to evaluate if brazilin is capable of alleviating inflammatory/degradative processes when OA conditions are already established.
On the way to human application, however, a pharmaceutical substance needs to be producible and accurately defined in qualitative, quantitative and economic terms. For this study, we isolated brazilin from CSE, and carefully confirmed its identity and purity. Of importance in this context, several groups already reported the successful chemical synthesis of brazilin [40] [41] [42] which will likely support its way to clinical use. Thereby, brazilin might even serve as a lead structure for the development of modified drugs with improved characteristics. 43 Moreover, due to its NF-kB-targeted activity, brazilin could be used as an alternative adjunct to non-steroidal anti-inflammatory drugs (NSAIDs), which are currently used for symptom management but not for structure modification in OA patients. Given the fact that cartilage is an avascular tissue and that the bioavailability of orally or intravenously administered drugs is limited, also the synovium might represent a target tissue for therapeutic strategies. We therefore suggest that upcoming studies should also address the molecular effects of brazilin in OA and RA synoviocytes.
Finally, we conclude that brazilin interferes with inflammatory processes and their mediators by blocking NF-kB-mediated catabolic activities in human cartilage and chondrocytes, thereby representing a novel agent with potential for the treatment of OA.
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